![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61P 31/00 | (2006.01) |
A61K 39/395 | (2006.01) | ||
A61K 9/19 | (2006.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 47/18 | (2017.01) | ||
A61K 47/26 | (2006.01) | ||
A61P 31/12 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
C07K 16/28 | (2006.01) | ||
A61K 39/00 | (2006.01) |
(11) | Number of the document | 2691112 |
(13) | Kind of document | T |
(96) | European patent application number | 12763896.3 |
Date of filing the European patent application | 2012-03-29 | |
(97) | Date of publication of the European application | 2014-02-05 |
(45) | Date of publication and mention of the grant of the patent | 2018-05-23 |
(46) | Date of publication of the claims translation | 2018-07-25 |
(86) | Number | PCT/US2012/031063 |
Date | 2012-03-29 |
(87) | Number | WO 2012/135408 |
Date | 2012-10-04 |
(30) | Number | Date | Country code |
201161470121 P | 2011-03-31 | US |
(72) |
SHARMA, Manoj K., US
NARASIMHAN, Chakravarthy Nachu, US
GERGICH, Kevin James, US
KANG, Soonmo Peter, US
|
(73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Stabilios antikūnų kompozicijos prieš žmogaus programuojamos mirties receptorių PD-1 ir susiję gydymo būdai |
STABLE FORMULATIONS OF ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 AND RELATED TREATMENTS |
Payment date | Validity (years) | Amount | |
2025-02-10 | 14 | 289.00 EUR |
2026-03-29 |